Shop
Showing 1201–1216 of 1229 results
-
Article: Update on cancer in pregnancy
€3.03 Only for registered clients -
Article: Update on the management of renal cell carcinoma: The BSMO expert panel recommendations
€3.03 Only for registered clients -
Article: Update to the Belgian follow-up guidelines for abnormal cervical screening results
€3.03 Only for registered clients -
Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma
€3.03 Only for registered clients -
Article: Updated results of the TAGS trial reinforce the clinical benefit and safety of TAS-102 in patients with advanced gastric cancer
€3.03 Only for registered clients -
Article: Updated survival data on maintenance therapy with olaparib in patients with platinum-sensitive recurrent ovarian cancer
€3.03 Only for registered clients -
Article: Updates on melanoma
€3.03 Only for registered clients -
Article: Urethral carcinoma: A rare disease but yet no clear guideline for treatment
€3.03 Only for registered clients -
Article: Using artificial intelligence in the diagnosis of breast cancer: First results after implementation in a radiology department of a breast clinic
€3.03 Only for registered clients -
Article: Value of testing for homologous recombination repair deficiency in newly diagnosed advanced-stage epithelial ovarian cancer: Recommendations for Belgian physicians
€3.03 Only for registered clients -
Article: Vascular malformations: Repurposing the role of anti-cancer targeted molecular inhibitors
€3.03 Only for registered clients -
Article: Volume 6, Issue 1, February 2012
€3.03 Only for registered clients -
Article: What about oligometastatic therapy in prostate cancer?
€3.03 Only for registered clients -
Article: What about oligometastatic therapy in prostate cancer?
€3.03 Only for registered clients -
Article: What About Oligometastatic Therapy In Prostate Cancer? Special,
€3.03 Only for registered clients -
Article: What are the treatment options for metastatic castration-resistant prostate cancer anno 2023?
€3.03 Only for registered clients